Arcutis Biotherapeutics Inc. (ARQT)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
23. 75
-0.22
-0.9178%
After Hours
$
+0.85 +3.5789% 24. 60
3B Market Cap
- P/E Ratio
- Div Yield
1.06M Volume
-3.88 Eps
$ 23.97
Previous Close 
Want to track ARQT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arcutis Biotherapeutics Inc. (ARQT) Statistics
Valuation metrics
Market Cap 3B
Enterprise value 3.05B
Trailing P/E (ttm) 107.7
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 6.41
Price/Book (mrq) 14.07
Enterprise Value/Revenue 6.58
Enterprise Value/EBITDA 69.22
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.54M
Average volume (90 days) 1.54M
Price summary
52-Week low 15.13
52-Week high 31.77
Beta -
50-Day moving average 27.29
200-Day moving average 23.96
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.06%
Operating margin 0.07%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.15%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 3.55
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.22
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.83
Total debt (mrq) -
Total Debt/Equity (mrq) 0.52
Current ratio (mrq) 2.92%
Book value per share (mrq) 1.69
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
